financetom
Business
financetom
/
Business
/
Oracle Insider Sold Shares Worth $346,769,981, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Oracle Insider Sold Shares Worth $346,769,981, According to a Recent SEC Filing
Mar 28, 2024 7:33 AM

10:09 AM EDT, 03/28/2024 (MT Newswires) -- Safra Catz, Director, Chief Executive Officer, on March 25, 2024, sold 2,750,000 shares in Oracle (ORCL) for $346,769,981. Following the Form 4 filing with the SEC, Catz has control over a total of 1,118,592 shares of the company, with 1,118,592 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1341439/000112760224011322/xslF345X03/form4.xml

Price: 125.69, Change: +0.42, Percent Change: +0.33

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Huntington Bancshares to Buy Certain Janney Montgomery Units
Market Chatter: Huntington Bancshares to Buy Certain Janney Montgomery Units
Nov 7, 2025
01:32 PM EST, 11/07/2025 (MT Newswires) -- Huntington Bancshares ( HBAN ) agreed to acquire select divisions of KKR (KKR)-owned Janney Montgomery Scott, Bloomberg News reported Friday, citing people with knowledge of the matter. The deal includes Janney's mergers and acquisitions advisory division, its public-finance group, and its fixed-income sales and trading operations, the report said Financial details weren't known,...
Eledon Pharmaceuticals' Lead Asset Fails In Mid-Stage Study, But Pushes Forward With Pivotal Study
Eledon Pharmaceuticals' Lead Asset Fails In Mid-Stage Study, But Pushes Forward With Pivotal Study
Nov 7, 2025
Eledon Pharmaceuticals, Inc ( ELDN ). stock is trading lower on Friday, with a session volume of 15.72 million, compared to its average volume of 1.24 million, according to Benzinga Pro. The company announced results from its Phase 2 BESTOW trial of tegoprubart for the prevention of organ rejection in patients receiving a de novo kidney transplant. A “de novo”...
ReNew Energy Global Gets $331 Million ADB Funding for Clean Energy Project in India
ReNew Energy Global Gets $331 Million ADB Funding for Clean Energy Project in India
Nov 7, 2025
01:39 PM EST, 11/07/2025 (MT Newswires) -- ReNew Energy Global ( RNW ) said Friday it is set to receive $331 million funding from the Asian Development Bank for its large-scale renewable energy project in Andhra Pradesh, India. The financing is part of a $477 million package, with the balance of $146 million to be arranged by ADB through other...
Proceed Acquires Special Delivery Services, Expanding Its Technology-Driven Service of Process Capabilities in Texas
Proceed Acquires Special Delivery Services, Expanding Its Technology-Driven Service of Process Capabilities in Texas
Nov 7, 2025
NEW YORK, Nov. 7, 2025 /PRNewswire/ -- Proceed  (formerly Counsel Press), a leader in technology-enabled litigation support, today announced the acquisition of Special Delivery Service, Inc. (Special Delivery), a Dallas-based provider of technology-driven service of process solutions. This acquisition expands Proceed's growing footprint in Texas following its recent acquisition of Court Record Research and further strengthens its position as one...
Copyright 2023-2026 - www.financetom.com All Rights Reserved